Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Drug Class (Bronchodilators (Beta 2-Agonists, Anticholinergics, Theophyllines), Phosphodiesterase Type 4 Inhibitors, Corticosteroids, Others), By Route of Administration (Oral and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Select a License Type that Suits your Business Needs
Excel Databook
US$ 2,200
Two thousand two hundred dollars
Single User License
( Full Report )
US$ 4,500
US$ 2,500
Two thousand five hundred dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
US$ 3,850
Three thousand five hundred dollars
Corporate User License
( Full Report )
US$ 10,000
US$ 6,000
Seven thousand five hundred dollars
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
AUS : 
INDIA :